Investigating the interaction between neuropsychiatry features and daily activities on social function in patients with Parkinson's disease with mild cognitive impairment

被引:8
作者
Chen, Yi-Ru [1 ]
Tan, Chun-Hsiang [2 ,3 ]
Su, Hui-Chen [4 ]
Chien, Chung-Yao [4 ]
Sung, Pi-Shan [4 ]
Lin, Tien-Yu [4 ]
Lee, Tsung-Lin [4 ]
Yu, Rwei-Ling [1 ]
机构
[1] Natl Cheng Kung Univ, Inst Behav Med, Coll Med, Tainan, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan
[4] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Neurol, Tainan, Taiwan
来源
BJPSYCH OPEN | 2022年 / 8卷 / 06期
关键词
Parkinson's disease; mild cognitive impairment; social functioning; assessment tool; influence variables; INSTRUMENTAL ACTIVITIES; SYMPTOMS; EXPENDITURES; DEMENTIA; PEOPLE; IMPACT;
D O I
10.1192/bjo.2022.611
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundSocial functioning is crucial for daily living and is an essential indicator of dementia in patients with Parkinson's disease. The pattern of social functioning in patients with Parkinson's disease without dementia (i.e. those who are cognitively intact or have mild cognitive impairment (PD-MCI)) and its determinants are unclear. AimsIn exploring the heterogeneity of social functioning among patients with Parkinson's disease-associated dementia, we determined the optimal cut-off score of the Parkinson's Disease Social Functioning Scale (PDSFS) for patients with PD-MCI, and the variables influencing patients' social functioning. MethodA total of 302 participants underwent the Mini-Mental State Examination (MMSE) and PDSFS; 120 patients with Parkinson's disease completed the measurements (MMSE, Activities of Daily Living Scale and Neuropsychiatric Inventory). Group comparisons, receiver operating characteristic curves, Spearman correlation and multiple and hierarchical regression analyses were conducted. ResultsThe PD-MCI group scored the lowest on the PDSFS (F = 10.10, P < 0.001). The PDSFS cut-off score was 53 (area under the curve 0.700, sensitivity 0.800, specificity 0.534). The MMSE (beta = 0.293, P = 0.002), Activities of Daily Living Scale (beta = 0.189, P = 0.028) and Neuropsychiatric Inventory (beta = -0.216, P = 0.005) scores predicted the PDSFS score. Further, there was an interaction effect between the Activities of Daily Living Scale and Neuropsychiatric Inventory scores on the PDSFS score (beta = 0.305, P < 0.001). ConclusionsWe determined a PDSFS cut-off score for detecting PD-MCI and found that patients with PD-MCI have social dysfunction. Future research should focus on the effects of neuropsychiatry symptoms and activities of daily living on social functioning, and tailor the intervention programme for patients with Parkinson's disease.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Biomarkers for Dementia and Mild Cognitive Impairment in Parkinson's Disease
    Delgado-Alvarado, Manuel
    Gago, Belen
    Navalpotro-Gomez, Irene
    Jimenez-Urbieta, Haritz
    Rodriguez-Oroz, Maria C.
    MOVEMENT DISORDERS, 2016, 31 (06) : 861 - 881
  • [42] Phase lag index and spectral power as QEEG features for identification of patients with mild cognitive impairment in Parkinson's disease
    Chaturvedi, Menorca
    Bogaarts, Jan Guy
    Kozak , Vitalii V.
    Hatz, Florian
    Gschwandtner, Ute
    Meyer, Antonia
    Fuhr, Peter
    Roth, Volker
    CLINICAL NEUROPHYSIOLOGY, 2019, 130 (10) : 1937 - 1944
  • [43] Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS)
    Monastero, Roberto
    Cicero, Calogero Edoardo
    Baschi, Roberta
    Davi, Marco
    Luca, Antonina
    Restivo, Vincenzo
    Zangara, Chiara
    Fierro, Brigida
    Zappia, Mario
    Nicoletti, Alessandra
    JOURNAL OF NEUROLOGY, 2018, 265 (05) : 1050 - 1058
  • [44] Functional Connectivity in Parkinson's Disease Patients with Mild Cognitive Impairment
    Wang, Qingguang
    He, Wei
    Liu, Dinghua
    Han, Bojun
    Jiang, Qitao
    Niu, Jiali
    Ding, Yunlong
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 2623 - 2630
  • [45] Memantine for the patients with mild cognitive impairment in Parkinson’s disease: a pharmacological fMRI study
    Shoji Kawashima
    Noriyuki Matsukawa
    BMC Neurology, 22
  • [46] Medication management and treatment adherence in Parkinson's disease patients with mild cognitive impairment
    Sumbul-Sekerci, Betul
    Hanagasi, Hasmet A.
    Bilgic, Basar
    Tufekcioglu, Zeynep
    Gurvit, Hakan
    Emre, Murat
    ACTA NEUROLOGICA BELGICA, 2023, 123 (03) : 823 - 829
  • [47] Memantine for the patients with mild cognitive impairment in Parkinson's disease: a pharmacological fMRI study
    Kawashima, Shoji
    Matsukawa, Noriyuki
    BMC NEUROLOGY, 2022, 22 (01)
  • [48] Association of Cognitive Activities of Daily Living (ADL) Function and Nonmotor Burden in Nondemented Parkinson's Disease Patients
    Becker, Sara
    Baeumer, Alena
    Maetzler, Walter
    Nussbaum, Susanne
    Tkaczynska, Zuzanna
    Sulzer, Patricia
    Timmers, Maarten
    Van Nueten, Luc
    Salvadore, Giacomo
    Brockmann, Kathrin
    Streffer, Johannes
    Berg, Daniela
    Liepelt-Scarfone, Inga
    NEUROPSYCHOLOGY, 2020, 34 (04) : 447 - 455
  • [49] Mild Cognitive Impairment in Patients With Parkinson's Disease Is Associated With Increased Cortical Degeneration
    Hanganu, Alexandru
    Bedetti, Christophe
    Jubault, Thomas
    Gagnon, Jean-Francois
    Mejia-Constain, Beatriz
    Degroot, Clotilde
    Lafontaine, Anne-Louise
    Chouinard, Sylvain
    Monchi, Oury
    MOVEMENT DISORDERS, 2013, 28 (10) : 1360 - 1369
  • [50] Mild cognitive impairment and cognitive reserve in Parkinson's disease
    Poletti, Michele
    Emre, Murat
    Bonuccelli, Ubaldo
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (08) : 579 - 586